These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 16546489)

  • 21. Diagnostic and surgical dilemmas in hereditary medullary thyroid carcinoma.
    Allen SM; Bodenner D; Suen JY; Richter GT
    Laryngoscope; 2009 Jul; 119(7):1303-11. PubMed ID: 19444888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medullary thyroid carcinoma: surgical treatment advances.
    Dionigi G; Tanda ML; Piantanida E
    Curr Opin Otolaryngol Head Neck Surg; 2008 Apr; 16(2):158-62. PubMed ID: 18327036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Asymptomatic bilateral adrenal pheochromocytoma in a patient with a germline V804M mutation in the RET proto-oncogene.
    Recasens M; Oriola J; Fernández-Real JM; Roig J; Rodríguez-Hermosa JI; Font JA; Galofre P; López-Bermejo A; Ricart W
    Clin Endocrinol (Oxf); 2007 Jul; 67(1):29-33. PubMed ID: 17466010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prophylactic thyroidectomy in children at risk for medullary thyroid carcinoma].
    Torres de Aguirre A; Martínez Carol A; Cabello Laureano R; García Valles C; Gómez Gila A; del Valle Núñez J
    Cir Pediatr; 2005 Jul; 18(3):106-8. PubMed ID: 16209369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutation analysis of the RET proto-oncogene and early thyroidectomy: results of a Portuguese cancer centre.
    Bugalho MJ; Domingues R; Santos JR; Catarino AL; Sobrinho L
    Surgery; 2007 Jan; 141(1):90-5. PubMed ID: 17188172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RET oncogene mutations in 75 cases of familial medullary thyroid carcinoma in Japan.
    Kameyama K; Okinaga H; Takami H
    Biomed Pharmacother; 2004; 58(6-7):345-7. PubMed ID: 15271413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. When is prophylactic thyroidectomy indicated for patients with the RET codon 609 mutation?
    Calva D; O'Dorisio TM; Sue O'Dorisio M; Lal G; Sugg S; Weigel RJ; Howe JR
    Ann Surg Oncol; 2009 Aug; 16(8):2237-44. PubMed ID: 19472011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lessons learned from the management of a rare genetic cancer.
    Cote GJ; Gagel RF
    N Engl J Med; 2003 Oct; 349(16):1566-8. PubMed ID: 14561800
    [No Abstract]   [Full Text] [Related]  

  • 29. Occurrence of the Cys611Tyr mutation and a novel Arg886Trp substitution in the RET proto-oncogene in multiple endocrine neoplasia type 2 families and sporadic medullary thyroid carcinoma cases originating from the central region of Portugal.
    Prazeres HJ; Rodrigues F; Figueiredo P; Naidenov P; Soares P; Bugalho MJ; Lacerda M; Campos B; Martins TC
    Clin Endocrinol (Oxf); 2006 Jun; 64(6):659-66. PubMed ID: 16712668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RET polymorphisms in codons 769 and 836 are not associated with predisposition to medullary thyroid carcinoma.
    Wiench M; Włoch J; Wygoda Z; Gubała E; Oczko M; Pawlaczek A; Kula D; Lange D; Jarzab B
    Cancer Detect Prev; 2004; 28(4):231-6. PubMed ID: 15350625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hereditary medullary thyroid carcinoma--genotype-phenotype characterization].
    Frank-Raue K; Heimbach C; Rondot S; Usadel KH; Meng W; Varma C; Fuchs-Hammoser R; Höppner W; Schulze E; Raue F
    Dtsch Med Wochenschr; 2003 Sep; 128(39):1998-2002. PubMed ID: 14508694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medullary thyroid carcinoma.
    Pacini F; Castagna MG; Cipri C; Schlumberger M
    Clin Oncol (R Coll Radiol); 2010 Aug; 22(6):475-85. PubMed ID: 20627492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The surgical management of medullary thyroid cancer.
    Dackiw AP
    Otolaryngol Clin North Am; 2010 Apr; 43(2):365-74, ix. PubMed ID: 20510719
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New directions in the treatment of thyroid cancer.
    You YN; Lakhani V; Wells SA
    J Am Coll Surg; 2007 Oct; 205(4 Suppl):S45-8. PubMed ID: 17916518
    [No Abstract]   [Full Text] [Related]  

  • 35. Multiple endocrine neoplasia 2A due to a unique C609S RET mutation presents with pheochromocytoma and reduced penetrance of medullary thyroid carcinoma.
    Kinlaw WB; Scott SM; Maue RA; Memoli VA; Harris RD; Daniels GH; Porter DM; Belloni DR; Spooner ET; Ernesti MM; Noll WW
    Clin Endocrinol (Oxf); 2005 Dec; 63(6):676-82. PubMed ID: 16343103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Editorial: germline variants within RET: clinical utility or scientific playtoy?
    Weber F; Eng C
    J Clin Endocrinol Metab; 2005 Nov; 90(11):6334-6. PubMed ID: 16275981
    [No Abstract]   [Full Text] [Related]  

  • 37. Mutational analysis of RET proto-oncogene among patients with medullary thyroid carcinoma and 'at risk' carriers from India.
    Pai R; Nehru GA; Samuel P; Paul MJ; Thomas N; Premkumar JA; Hephzibah J; Shanthly N; Oommen R; Nair A; Seshadri MS; Rajaratnam S
    Clin Endocrinol (Oxf); 2011 Oct; 75(4):571-2. PubMed ID: 21521337
    [No Abstract]   [Full Text] [Related]  

  • 38. A perspective from pediatric endocrinology on the hereditary medullary thyroid carcinoma syndromes.
    Waguespack SG
    Thyroid; 2009 Jun; 19(6):543-6. PubMed ID: 19499985
    [No Abstract]   [Full Text] [Related]  

  • 39. Medullary thyroid cancer in a patient with Hirschsprung disease with a C609Y germline RET-mutation.
    de Groot JW; Sijmons RH; Links TP; Plukker JT; Hofstra RM
    J Pediatr Gastroenterol Nutr; 2005 Feb; 40(2):226-9. PubMed ID: 15699703
    [No Abstract]   [Full Text] [Related]  

  • 40. The role of prophylactic surgery in cancer prevention.
    You YN; Lakhani VT; Wells SA
    World J Surg; 2007 Mar; 31(3):450-64. PubMed ID: 17308850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.